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Abstract
Background: Globally there are about 3.3million children under the age of 15 years living with HIV. Of this number,
88% live in sub-Saharan Africa. In Ghana, an estimated 33,000 children were said to be living with the HIV infection
in 2012. Lack of disclosure adversely affects the well-being of the child, including access to paediatric HIV treatment
and care and adherence to treatment. However, the greatest psychosocial challenges that parents and caregivers of
HIV-infected children face is disclosure of HIV status to their infected children. This study sought to determine the
prevalence of and the barriers to the disclosure of HIV status to infected children and adolescents in Lower Manya-Krobo
District in Ghana.
Methods: A cross sectional study with a sample of 118 caregivers of HIV infected children and adolescents aged 4–19
years attending three HIV clinics in the Lower Manya Krobo District, and 10 key informants comprising of healthcare
workers and HIV volunteer workers involved in the provision of care to infected children and their families.
Results: The prevalence of disclosure was higher. Main barriers to disclosure identified in this study included age of
child, perceived cause of HIV, stigma attached to HIV, child’s inability to keep diagnosis to self and fear of psychological
harm to child.
Conclusion: There is the need for the Ghana Health Service in conjunction with the Ghana Aids Commission and the
National Aids Control Programme to develop comprehensive context-based disclosure guidelines.
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Background
Globally there are about 3.3million children under the
age of 15 years living with HIV. Of this number, 88% live
in sub-Saharan Africa [1]. In 2011 alone, a total of
330,000 children under the age of 15 years were newly
infected, 90% of who live in sub-Saharan Africa [2]. In
Ghana, an estimated 33,000 children were said to be liv-
ing with the HIV infection in 2012 (UNAIDS, 2012).
One of the greatest psychosocial challenges that
parents and caregivers of HIV-infected children face is
disclosure of HIV status to their infected children, even
though there are a myriad of benefits associated with
disclosure [3].
The World Health Organisation (WHO) reports how-
ever that, disclosure of HIV status to infected children,
the gateway to treatment has failed to keep pace with
the increasing access to HAART. The WHO also recog-
nizes that the lack of disclosure ultimately affects the
well-being of the child, including access to paediatric
HIV treatment and care and adherence to treatment. In
view of this, the WHO recommends that as part of their
long term management, children of school age should be
told their HIV status and further recommends that
younger children should be told their status incrementally
to accommodate their cognitive skills and emotional
maturity, in preparation for full disclosure [4]. Similarly,
the American Academy of Paediatrics recommends that
children of school age and all adolescents should be told
their diagnosis. The Academy further stresses on the
importance of adopting an individualized approach in the
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disclosure process. It also suggests that younger children
need not know their diagnosis but should have their
illness discussed with them [5].
There are differences in the HIV disclosure prevalence
rates among countries which have been reported by
several researchers. For example, it is reported that in
India, the disclosure rate is 14% [6] and 13% in Nigeria
[7]. In the study by Feinstein et al. [8], 77% of adoles-
cents older than 11 years had been told their HIV diag-
nosis. Similarly, in a prospective cohort study, 57% of
10–16 year olds knew that they were infected [9]. The
higher disclosure rate observed in the resource rich
countries might reflect a better education of the care-
givers and understanding of the importance of
disclosure.
Disclosure of health status to individuals, especially
children is a fundamental human right issue that cannot
be ignored. For example, in article 24 of the United
Nations Convention on the Rights of the Child, children
have the right to good quality health care – the best health
care possible – to safe drinking water, nutritious food, a
clean and safe environment, and information to help them
stay healthy. It is therefore important for parents and
caregivers to provide adequate information for children
who are HIV positive. Provision of such information
would help protect the health rights of these children.
Available data from two independent studies con-
ducted in Ghana and South Africa suggest that very few
children living with HIV are actually aware of their
diagnosis [10]. These studies reported a prevalence of
9% [11] and 21% [12] respectively. It must however be
mentioned that these studies did not explore the barriers
to and benefits of HIV status disclosure.
The traditional and cultural orientation of Ghanaians
puts individuals, their behaviour and their general
health status under the scrutiny of the larger family
members. The Ghanaian society is highly traditional
and has some level of relatively high communal spirit.
Family members do not want others to taint the
image of the larger family and would try as much as
possible to protect the long standing image within the
society. The orientation of Ghanaian communities
means that individual behaviour casts a reflection on
the larger family and/or community group. In most
Ghanaian communities, communal spirit overrides
individual aspirations, people are therefore afraid to
know their HIV status due to the possible spontan-
eous negative reaction from members of the society.
The reaction may include stigma, labelling and social
distance or withdrawal. Ghanaian society has a way of
categorising and assigning expectations to its mem-
bers. When people perceive individuals as possessing
socially unacceptable attributes, in this case HIV, they
assign negative qualities to the person and this results
in intense devaluation of the individual. This trad-
itional approach infringes on the fundamental rights
of children and family members in the area of right
to dignity. This results in the marginalisation of
people living with HIV.
In Ghana, one of the main factors influencing the
decision to disclose status of certain sicknesses such as
HIV is a desire to protect the family from shame. This is
because, in some traditional communities, certain
sicknesses are seen as very shameful and are caused by
the supernatural when one offends the ‘gods’.
This study therefore aimed to determine the preva-
lence of disclosure of HIV status to infected children
and adolescents and to examine the barriers to the
disclosure process.
Methods
The study was carried out in three hospitals in the
Lower Manya-Krobo District of the Eastern Region of
Ghana that offer paediatric HIV care. These hospitals
were the Atua Government Hospital, the St. Martins de
Porres Hospital and the Akuse Government Hospital. A
cross sectional design employing a mixture of quantita-
tive and qualitative research methods was used. The
advantage of using a mixed method approach was to
gain a better and thorough understanding of the subject.
The quantitative aspect of the study involved the ad-
ministration of structured questionnaires to respondents
comprising caregivers of HIV infected children and ado-
lescents aged 4–19 years attending the three hospitals.
One hundred and eighteen(118) caregivers were con-
veniently sampled within a period of 3 months. Care-
givers who had come to the hospital with their children
at the times of our visits were approached and the pur-
pose of the study was explained to them. Those who
were readily willing to participate in the study were
given the questionnaire to fill. Respondents were asked
questions such as ‘what in your view is the main barrier
that prevents you as a caregiver from disclosing the HIV
diagnosis to your infected children?
In order to allay respondents’ fear of inadvertent
disclosure of an infected child’s status, children were not
interviewed at all. For this same reason, caregivers were
not interviewed. The qualitative aspect of the study
occurred within the same period and it included
in-depth interviews with ten (10) purposefully selected
key informants comprising mainly of healthcare workers
and HIV volunteer workers involved in the provision of
care to infected children and their families. The inter-
views were conducted by three research assistants who
were recruited and trained by the researchers. The inter-
views were conducted at the hospital premises for the
caregivers and for the healthcare workers, it took place
at their offices. The interviews were conducted in Twi
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language (Local language). The interviews were tape-
recorded with audio recorder together with notes that
were taken during the interaction period. Transcripts
were coded on dominant themes that were developed
from the responses which were given by participants,
and were analysed in duplicate, with each analyst blind
to the summary of the other. Coding was undertaken by
a team of 3research assistants under the supervision of
the researchers. Members were paired to read a selected
number of transcripts, and both members in each pair
read all transcripts independently. The entire team then
converged to discuss emerging themes and to resolve
disputes on coding. One team member read all the
transcripts and facilitated the discussion. The division of
transcripts into sections helped in the management of
the data. The team compared summaries and involved
extra readers to resolve any differences. Data-led
approach thematic analysis was used to analyse the data
after transcribing the interviews verbatim.
Limitations of study
In this study, disclosure was based on the subjective
reporting of the caregivers and consequently might
therefore not reflect the child’s perception. Another
limitation of the study could be related to the use of
convenience sampling technique which is prone to




Socio-demographic characteristic of caregivers and
healthcare workers
Table 1 presents the socio-demographic characteristics
of caregivers who participated in the study. The mean
age of the caregivers was 48 years. Majority (55.9%) of
the caregivers were HIV positive. Most of the caregivers
(47.5%) were the child’s biological mother and only 3.4%
of them had tertiary level education.
In terms of healthcare workers, 50% were between
the ages of 30–39years, 30% were either exactly
40 years or more while 20% were below 30 years.
Regards to their status within the hospitals, 40% were
medical doctors, 30% were nurses while another 30%
were volunteers or counsellors who were working
with HIV patients. About 60% of the healthcare
workers had worked with the HIV unit between 5
and 9 years, 20% had worked for 10 years or more
and 20% had worked less than 5 years.
The characteristics of the children whose caregivers
participated in the study are presented in Table 2.
The average age of the children was 11 years. The re-
sults revealed that most (36.8%) of the children were
first diagnosed with HIV from ages 6 – 10 years. The
majority (94.1) of the children were on antiretroviral
medication whereas only 5.9% were not on antiretro-
viral medications and most (94.9%) of the children
were in school.
Prevalence of disclosure of HIV status to infected children
The prevalence of disclosure of HIV status to infected
children is presented in Table 2 the majority (66.7%)
of the children had not been told their HIV positive
status. The results also showed that 89.7% of those
who had not disclosed indicated they had intentions
of telling their children their HIV positive diagnoses
in the near future.






Age of Caregiver ▪ 21–30 7 5.9
▪ 31–40 33 28.0
▪ 41–50 34 28.8





HIV status of caregiver ▪ Positive 66 55.9
▪ Negative 40 33.9
▪ Unknown 12 10.2
Relationship with the
child
▪ Mother 56 47.5
▪ Father 9 7.6
▪ Grandparent 31 26.3
▪ Other 22 18.6
Occupation of Caregivers ▪ Unemployed 11 9.4
▪ Farming 19 16.2
▪ Trading 487 41.0
▪ Artisanship 18 15.4
▪ Public 13 11.1
▪ Private 8 6.8
Age group of healthcare
workers
• 20–29 years 2 20.0
• 30–39 years 5 50.0
• 40 years and
above
3 30.0
Status within the hospital • Medical Doctor 4 40.0




Number of years worked
in the hospital
• Less than 5 years 2 20.0
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The barriers to disclosure of HIV status to infected children
The barriers to disclosure of HIV status to infected
children are presented in Table 3. The study elicited
views of caregivers about telling the child his/her HIV
status. Most respondents (77.7%) had positive views
about disclosing the HIV status of an infected child
to him and the majority (43.2%) of the respondents
reported the preferred age of disclosure of HIV status
to infected children to be between 14 and 17 years.
With regard to the barriers to disclosure, majority
(67.7%) reported that the child might be too young to
understand the information. Caregivers however did
not provide reasons to why they thought their chil-
dren might be too young to understand the
information.
Qualitative components
The qualitative components of the results of the study
have been presented under the sub-themes which
emerged from the analysis of the data. The qualitative
component of the study explored the barriers to disclos-
ure process from the perspective of those who provide
paediatric care to the caregivers and their children. Four
main themes emerged from the data concerning the
barriers that prevent caregivers from disclosing the
status of their infected children/adolescents to them: age
of child; fear of the aftermath of disclosure; need for
disclosure; and inability to get child to keep his/her diag-
nosis to him/herself.
Age of Child
Age of the child came up as a very important barrier to
disclosure. Most caregivers considered children younger
than 13 years as immature and incapable of understand-
ing their illness. According to a trained counsellor and a
health care provider at one of the hospital’s HIV Testing
and Counselling unit “Some of the children are under
aged especially those under 13 years”. Similarly, another
trained counselor and a health care provider in another
HIV Counseling and Testing unit of one of the hospitals
Table 2 Characteristics of Children whose caregivers took part
in the study
Variables Frequency Percentage (%)
(n = 118)
Age of Child
▪ 4–6 24 20.3
▪ 7–11 33 28
▪ 12–16 45 38.1
▪ 17–19 16 13.6
Mean (SD); Min/max 11 (4.31); 4/19
Age of child at first diagnosis with HIV
▪ Less than a year 6 5.3
▪ 1–5 years 12 10.5
▪ 6– 10 years 42 36.8
▪ 11–15 years 33 28.9
▪ 16–18 years 21 18.4
Child on Antiretroviral medication
▪ Yes 111 94.1
▪ No 7 5.9
Child Currently in School
▪ Yes 112 94.9
▪ No 6 5.1
Level of Education of Child
▪ Kindergarten 10 9.2
▪ Nursery 7 6.4
▪ Primary 63 57.8
▪ JHS 29 24.8
▪ SHS 2 1.8
Age at disclosure for children who have been told (n = 39)
▪ 7–11 3 7.7
▪ 12–16 24 61.5
▪ 17–19 12 30.8




Opinion about telling a child his/her
HIV status
(n = 118)
− Positive 87 77.7
− Not sure 3 2.5
− Negative 27 22.9
Preferred age of disclosure
− 6–9 5 4.2
–10–13 33 28.0
− 14–17 51 43.2
− 18–19 29 24.6
Mean (SD); min/max 14.9 (3.01) 6/
19
Face barrier in telling the child his/her HIV status
− Yes 93 79.1
− No 25 20.9
Barriers to the disclosure of status to
child (n = 105)
6 9.2
− Fear of psychologically harm to child 44 67.7
− Child may be too young to understand 12 18.5
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indicated that most of the children are considered too
young to be able to understand their illness”
“Some of the caregivers may find the children too
young to understand. Also most of the children have
lost one or both of their parents so by disclosing you
may end up also telling the children about some other
things which they don’t want them to know—such as
the death of their parents. They therefore want to wait
till the child is old enough to understand and take in
all of these other issues before they tell them” (male
caregiver individual interview).
Fear of aftermath of disclosure
Generally, the possibility of some undesired conse-
quences arising out of disclosure served as an
important barrier to disclosure. Some of these pos-
sible undesirable consequences include the effect of
disclosure on mother-child relationship, child’s emo-
tional and psychological wellbeing and the perception
of mothers that their children may see them as
having led irresponsible lives to have contracted the
infection
“…Caregivers are afraid that after disclosure,
something bad may happen to them or to the children.
For instance the child may refuse his/her medications…
if he or she has entered his/her teenage years may
blame their caregiver (mother) for infecting him/her
with the disease. The child may even get angry and
leave home” (HIV Counsellor, individual interview).
“Others are also scared of aftermath of the disclosure.
They fear something bad might come out of the
disclosure. Telling the child of the condition and
explaining to the child how the infection came about
they are not sure what will happen…they are scared
that the child may distant himself/herself from the
parents or may even stop taking their medication.
Some may even begin to have suicidal ideations.”
(Physician assistant and a trained HIV counselor,
individual interview).
Stigmatization of HIV
Another major barrier to disclosure of HIV status was the
stigma associated with the illness. They were of the view
that in their communities, HIV is seen as sickness caused
by the supernatural powers as a result of either punish-
ment or breaking communal taboos. Once people get to
know of your HIV status, you are labeled and people will
not be willing to interact with you. This will affect people’s
participation in community activities. In order to avoid
these negative attributions and labeling, caregivers decide
not to disclose the status to the children.
“People still perceive HIV as something caused by the
spirits. Because of this, the whole community will
withdraw from you if they become aware of your
status as positive” (Health service provider,
individual interview).
The need for disclosure
For a number of caregivers, there is just no need to
disclose to the child his/her HIV positive status. Such
caregivers were said to be either ignorant or not moti-
vated to disclose to the child.
“Some of the caregivers also don’t deem it necessary to
disclose to the children who don’t ask questions about
reason for medication and who are adherent to their
medication regimen”(Trained counselor and a health
service provider, individual interview).
Inability to get child to keep his diagnosis to him/herself
The stigma attached to HIV and the attitude of children
as ‘free talkers’ makes it difficult to make it known to
the children their HIV positive status. Study participants
were of the view children are more likely to disclose
their status either wittingly or unwittingly to their
friends through conversations and were wary of the
consequences should this happen.
“They may also not be able to keep the diagnosis to
themselves. Because of the stigma attached to the
condition, they want to make sure that the child is old
enough to keep the diagnosis in order not to let out
family secrets.”(Volunteer worker at an HIV Testing
and Counseling Unit, individual interview).
“Telling children can be problematic because children
talk a lot. They may actually disclose the diagnosis to
others. This will reveal the status of the mother and
the rest of the family, which can result in stigmatization
towards them” (Trained counselor and health service
provider, individual interview).
Discussion
The study sought to determine the prevalence of disclos-
ure and to examine the barriers that caregivers face
during disclosure using a mixed method approach. The
prevalence of disclosure to children with HIV in this
study was 33.3%. The higher prevalence rate observed in
this study might be attributed to the increased number
of adolescents (mean age of 11, range 4–19 years) in this
study. However even when compared with studies
involving adolescents and older children, the prevalence
obtained in the current study is still very low. In the
study by Feinstein et al. [8], 77% of adolescents older
than 11 years had been told their HIV diagnosis.
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In this study, even though most caregivers agreed that
disclosure was important, they preferred to wait till the
children were older before disclosing to them their diag-
nosis. The preferred age of disclosure ranged from 6 to
19 years with a mean age of 14.9 years.
Consistent with findings of the quantitative compo-
nent of the study discussed above, the qualitative
component revealed a generally low rate of disclosure in
the district. Additionally, this component also revealed
that not only do caregivers like to wait till early teens
before disclosure, but also like to wait till they are either
prompted by the health care worker or until the child
begins to refuse medications on the grounds that they
don’t feel sick and therefore do not see the need to take
medications daily. This is similar to findings in a study
by Hammami et al. [13] which suggested that sometimes
children do not understand why they have to take
medications when they don’t feel sick.
Under these circumstances caregivers and health care
workers are forced to disclose to older children. For chil-
dren considered too young, caregivers and health care
workers try to provide just enough information often
without mentioning the name of the disease to enable
such children take their medications. This approach to
disclosure often referred to as partial disclosure in which
bits of information are given out to children without
mention of the name of the disease has been used by
some caregivers as reported in a number of studies
including those conducted by Brown et al. [7] and
Oberdorfer et al. [14].
This study revealed that most caregivers face barriers
when it comes to the disclosure of HIV status to their
infected children. The most commonly mentioned
barrier to disclosure according to caregivers was that the
child was too young to understand his/her illness. A
qualitative component of this same study further lends
support to this finding reporting that most caregivers
considered children below the age of 13 years as being
incapable of understanding their illness. A perception
which is even worse for children below the age of
10 years who according to respondents are not told their
diagnosis at all.
The second most commonly cited barrier from this
study was the fear that children would not be able to
keep their diagnoses to themselves, another finding
which is common to both the quantitative and qualita-
tive components of the study. However, the failure of
the caregivers to disclose the child’s HIV status to him/
her may also stem from their own desire to avoid stig-
matisation when it becomes known that they are also
HIV-infected. This may be a plausible reason for non-
disclosure from the perspective of the caregivers since
HIV and AIDs still remains highly stigmatised condition
in Ghana.
In most Ghanaian communities, communal spirit
overrides individual aspirations, people are therefore
afraid to know their HIV status due to the possible
spontaneous negative reaction from members of the
society. The reaction may include stigma, labelling
and social distance or withdrawal. Ghanaian society
has a way of categorising and assigning expectations
to its members. When people perceive individuals as
possessing socially unacceptable attributes in this case
HIV, they assign negative qualities to the person and
this results in intense devaluation of the individual. In
order for children not to be stigmatised and excluded
from mainstream society, caregivers resort to conceal-
ing the HIV status of children. The strategies adopted
by caregivers in this Ghanaian society is consistent
with the theory of stigma propounded by Goffman
[15] that there is always deliberate concealment of in-
formation about the stigmatising attribute when it is
not immediately visible or known by others. Under
such situations management of information about the
stigmatising attribute becomes a central issue. This is
because all humans will like others to see and inter-
act with them as normal individuals in society,
Again, the cultural interpretation of diseases such as
HIV/AIDS in Ghana might have also influenced the
decision of caregivers not to disclose the HIV status
of the children. In most traditional communities in
Ghana, HIV is still seen as spiritual sickness inflicted
by the supernatural as a result of sins committed.
Such stigmatising cultural meanings can have serious
impact on the illness experience of patients and can
worsen the social suffering of the individual even
more than the symptoms of the disease As a result
people hesitate or choose not to disclose their status
to family members, friends or neighbours for fear of
being ostracised. The belief about the transmission
and curability of HIV/AIDS is a reflection of the way
Ghanaian society understands the disease.
In addition, the caregivers indicated that fear of
psychological and emotional harm to the child is a
barrier to disclosure. This is because, HIV/AIDS is a
condition that evokes shame and condemnation across
many societies in Ghana and consequently could result
in traumatic experience such as depression and harmful
behaviour in children and or adolescents when they
learn that they have contracted this infection. Perhaps, it
is in view of this that caregivers fail to disclose the HIV
status to their children in order to avert the psycho-
logical, emotional and social consequences that may
attend disclosure.
Finally, one of the reasons less commonly referred
to for non-disclosure in this study were caregivers’
feeling of shamefulness about their illnesses, fear of
rebellion from older children for passing on illness to
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them and caregivers’ perceived lack of the know-how
for disclosure. This finding is consistent with a study
by Sirikum et al. [16] which reported that most care-
givers simply did not know how to disclose and
therefore relied on the health care worker to disclose
to their infected children.
Another set of barrier was the discretion of care-
givers based on their fears of the possibility of un-
desirable consequences following the aftermath of
disclosure and the fact that they saw no need to. Key
among the numerous fears expressed by caregivers
was the anticipation that children would ask how par-
ents got infected and that answering such a question
would compel biological caregivers to give detailed
explanation of their sexual activities in an attempt to
explain the nature of the illness to the child.
With respect to need for disclosure, this component
of the study revealed that caregivers only saw the
need to disclose if children were having troubles ad-
hering to their medications or if they asked probing
questions about their illness or medications. For par-
ents who argue along this line, it may seem that the
only reason they may have for disclosing to the child
is to make him/her adhere to the medications. There
is therefore the need for health care workers to edu-
cate caregivers about the several other benefits that
are associated with disclosure. This will provide ad-
equate reason for caregivers to disclose to their chil-
dren even if children are neither refusing medications
nor asking probing questions about their illness.
Conclusion
The data obtained from this study suggests a low preva-
lence of disclosure of HIV status to infected children in
the Lower Manya-Krobo district of the Eastern region of
Ghana. Among the several barriers identified in the
study are the age of the child, the fear that the child
might not keep the diagnosis to self and the fear of emo-
tional and psychological harm to the child. Given that
all the above-mentioned barriers are child-related, the
data appears to suggest that caregivers delay HIV
disclosure in an attempt to protect their infected
children. However, in reality, HIV disclosure to children
is delayed to a large extent to protect the caregivers
from their personal fears such as fear of blame from
children that could mar their relationship with the child
as well as fear of having to answer questions about past
sexual behaviour. Caregivers’ perception that disclosure
may be needless when children are apparently taking
medication and not asking probing questions about their
illness should serve as a basis for health care workers to
step up the provision of information and education
about the possible benefits of disclosure.
Recommendations
There is the need for the Ghana Health Service in
conjunction with the Ghana Aids Commission and the
National Aids Control Programme to develop compre-
hensive context-based disclosure guidelines.
Again, it is recommended that stakeholders should
adopt the recently released WHO guidelines to the local
context of the caregivers. Such guidelines should be part
of a comprehensive care programme that focuses on im-
proving support for caregivers and infected children dur-
ing disclosure.
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